Virtu Financial LLC

Position in NVS — Novartis AG

CIK 1533964 New York, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,782,877

+$2,310,811 QoQ

Shares Held

17,757

+418.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#358

of 1,603 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Virtu Financial LLC holds $14,372,542 across 6 Drug Manufacturers - General names. NVS ranks #2 (19.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	5,787	$6,941,101
2	NVS	Novartis AG This page	17,757	$2,782,877
3	PFE	Pfizer Inc	97,068	$2,337,397
4	GILD	Gilead Sciences, Inc.	10,835	$1,368,893
5	SNY	Sanofi	22,088	$942,274
6	SCLX	Scilex Holding Co	34,797	$0

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,782,877	17,757	+418.6%	Shares	Defined	2026-08-13
2025-12-31	$472,066	3,424	+54.0%	Shares	Defined	2026-02-23
2025-03-31	$247,931	2,224	-78.4%	Shares	Defined	2025-05-12
2024-12-31	$999,860	10,275	+176.7%	Shares	Defined	2025-02-11
2024-09-30	$427,184	3,714	-16.1%	Shares	Defined	2024-11-20
2022-12-31	$401,708	4,428	-73.3%	Shares	Defined	2023-02-15
2022-09-30	$1,261,081	16,591	+201.3%	Shares	Defined	2022-11-07
2022-06-30	$465,422	5,506	+7.1%	Shares	Defined	2022-08-09
2021-09-30	$420,512	5,142	-53.4%	Shares	Defined	2021-11-12
2021-03-31	$942,673	11,028	+269.0%	Shares	Defined	2021-05-19
2020-12-31	$282,251	2,989	-76.8%	Shares	Defined	2021-02-24
2020-09-30	$1,120,566	12,886	—	Shares	Defined	2020-12-11
No filing history on record for this holder in this stock.